Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Puma Biotechnology, Inc.
Condition: Early Stage HER2+ Breast Cancer
NCT02400476
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal
Stopped reason
Context when available
No stop reason available in the current public record.